Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$866,419
+$274,891 QoQ
Shares Held
18,073
+12.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#559
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FAIRFIELD, BUSH & CO. holds $16,010,185 across 9 Drug Manufacturers - General names. NVO ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,869 | $3,441,164 | |
| 2 | NVS |
Novartis AG
|
19,239 | $3,015,136 | |
| 3 | MRK |
Merck & Co., Inc.
|
20,842 | $2,678,197 | |
| 4 | JNJ |
Johnson & Johnson
|
8,732 | $2,217,666 | |
| 5 | ABBV |
AbbVie Inc.
|
7,031 | $1,769,280 | |
| 6 | AMGN |
Amgen Inc
|
2,933 | $1,062,097 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
18,073 | $866,419 | |
| 8 | PFE |
Pfizer Inc
|
29,294 | $705,399 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $866,419 | 18,073 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $591,528 | 16,096 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $906,376 | 17,814 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $972,739 | 17,530 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,187,765 | 17,209 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,182,077 | 17,023 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,352,578 | 15,724 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,200,889 | 18,484 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,309,533 | 16,180 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,985,320 | 15,462 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,428,334 | 13,807 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $499,442 | 5,492 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $768,045 | 4,746 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $4,415,498 | 27,746 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $405,478 | 2,996 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $318,417 | 3,196 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $356,130 | 3,196 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $354,915 | 3,196 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $357,952 | 3,196 | Shares | Sole | 2022-05-12 | |
| 2021-09-30 | $2,716,698 | 28,296 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,370,355 | 28,296 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,954,910 | 28,996 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,139,854 | 30,635 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,274,526 | 32,760 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $2,241,707 | 34,235 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,283,988 | 37,940 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||